Press Resease

Osteoarthritis Drug Market - Global Industry Analysis

Osteoarthritis Drug Market by Drug Class (NSAIDs, Corticosteroids, Viscosupplementation Agents, and Others), by Route of Administration (Topical, Parenteral, and Oral), and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2025

Published Date: 24-Jan-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3760 Status : Published

Global osteoarthritis drug market expected to generate around USD 10,327 million by 2025, at a CAGR of around 8.1% between 2019 and 2025. The primary factor likely to drive the global osteoarthritis drug market over the estimated timeframe is the constantly rising aging population.

Description

The report covers a forecast and an analysis of the osteoarthritis drug market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the osteoarthritis drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the osteoarthritis drug market on a global level.

In order to give the users of this report a comprehensive view of the osteoarthritis drug market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Osteoarthritis Drug Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the osteoarthritis drug market by segmenting the market based on drug class, route of administration, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market are estimated from 2019 to 2025.

Based on drug class, the osteoarthritis drug market is segmented as NSAIDs, corticosteroids, viscosupplementation agents, and others. By route of administration, the osteoarthritis drug market is segmented into topical, parenteral, and oral. Based on distribution channel, the osteoarthritis drug market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further division into major countries, including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some major players of the global osteoarthritis drug market include Pfizer Inc., Horizon Pharma plc, Ferring B.V., Bioventus, Inc., Sanofi, Flexion Therapeutics, Inc., Alkem Laboratories, Anika Therapeutics, Inc., Chugai Pharmaceutical Co., Limited, and Zimmer Biomet Holdings, Inc., among others.

This report segments the global osteoarthritis drug market into:

Global Osteoarthritis Drug Market: Drug Class Analysis

  • Corticosteroids
  • NSAIDs
  • Viscosupplementation Agents 
  • Others

Global Osteoarthritis Drug Market: Route of Administration Analysis

  • Oral
  • Parenteral
  • Topical

Global Osteoarthritis Drug Market: Distribution Channel Analysis

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Osteoarthritis Drug Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Osteoarthritis Drug Market, 2016 - 2025 (USD Million)
    • 2.2. Global Osteoarthritis Drug Market: Snapshot
  •  
  • Chapter 3. Osteoarthritis Drug Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Osteoarthritis Drug Market drivers: Impact analysis
      • 3.2.2. Increased prevalence of Osteoarthritis
      • 3.2.3. increase in healthcare facilities, expenditure on advanced and developing healthcare facilities
    • 3.3. Market Restraints
      • 3.3.1. Side-effects of Osteoarthritis Drug
      • 3.3.2. Low adoption rate
    • 3.4. Opportunities
      • 3.4.1. High spending on R&D
      • 3.4.2. Adoption of innovative products
      • 3.4.3. FDA Approval
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Drug Class
      • 3.6.2. Market attractiveness analysis, by Route of Administration
      • 3.6.3. Market attractiveness analysis, by Distribution Channel
      • 3.6.4. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Osteoarthritis Drug Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Osteoarthritis Drug Market: company market share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Drug Class Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Osteoarthritis Drug Market - Drug Class Analysis
    • 5.1. Global Osteoarthritis Drug Market: Drug Class overview
      • 5.1.1. Global Osteoarthritis Drug Market revenue share, by Drug Class, 2016 and 2025(USD Million)
    • 5.2. Corticosteroids
      • 5.2.1. Global corticosteroids market, 2016 - 2025(USD Million)
    • 5.3. NSAIDs
      • 5.3.1. Global NSAIDs market, 2016 - 2025(USD Million)
    • 5.4. Viscosupplementation agents
      • 5.4.1. Global Viscosupplementation agents market, 2016 - 2025(USD Million)
    • 5.5. Others
      • 5.5.1. Global Others market, 2016 - 2025(USD Million)
  •  
  • Chapter 6. Global Osteoarthritis Drug Market - Route of Administration Analysis
    • 6.1. Global Osteoarthritis Drug Market: Route of Administration overview
      • 6.1.1. Global Osteoarthritis Drug Market revenue share, by Route of Administration, 2016 and 2025(USD Million)
    • 6.2. Oral
      • 6.2.1. The global Oral market, 2016 - 2025(USD Million)
    • 6.3. Parenteral
      • 6.3.1. Global Parenteral market, 2016 - 2025(USD Million)
    • 6.4. Topical
      • 6.4.1. Global Topical market, 2016 - 2025(USD Million)
  •  
  • Chapter 7. Global Osteoarthritis Drug Market - Distribution Channel Analysis
    • 7.1. Global Osteoarthritis Drug Market: Distribution Channel overview
      • 7.1.1. Global Osteoarthritis Drug Market revenue share, by Distribution Channel, 2016 and 2025(USD Million)
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global Osteoarthritis Drug Market for Hospital Pharmacies, 2016 - 2025(USD Million)
    • 7.3. Retail Pharmacies
      • 7.3.1. Global Osteoarthritis Drug Market for Retail pharmacies, 2016 - 2025(USD Million)
    • 7.4. Online Pharmacies
      • 7.4.1. Global Osteoarthritis Drug Market for online pharmacies, 2016 - 2025(USD Million)
  •  
  • Chapter 8. Global Osteoarthritis Drug Market - Regional Analysis
    • 8.1. Global Osteoarthritis Drug Market: Regional overview
      • 8.1.1. Global Osteoarthritis Drug Market revenue share, by Region, 2016 and 2025
    • 8.2. North America
      • 8.2.1. North America Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
      • 8.2.2. North America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
      • 8.2.3. North America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.2.4.2. The U.S. Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.2.4.3. The U.S. Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.2.5.2. Rest of North America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.2.5.3. Rest of North America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
      • 8.3.2. Europe Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
      • 8.3.3. Europe Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.3.4.2. Germany Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.3.4.3. Germany Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.3.5. UK
        • 8.3.5.1. UK Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.3.5.2. UK Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.3.5.3. UK Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.3.6.2. France Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.3.6.3. France Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.3.7.2. Rest of Europe Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.3.7.3. Rest of Europe Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
      • 8.4.2. Asia Pacific Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
      • 8.4.3. Asia Pacific Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.4.4.2. China Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.4.4.3. China Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.4.5.2. Japan Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.4.5.3. Japan Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.4.6.2. India Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.4.6.3. India Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.4.7.2. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.4.7.3. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
      • 8.5.2. Latin America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
      • 8.5.3. Latin America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.5.4.2. Brazil Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.5.4.3. Brazil Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
        • 8.5.5.2. Rest of Latin America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
        • 8.5.5.3. Rest of Latin America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Osteoarthritis Drug Market revenue, by Drug Class, 2016 - 2025(USD Million)
      • 8.6.2. The Middle East and Africa Osteoarthritis Drug Market revenue, by Route of Administration, 2016 - 2025(USD Million)
      • 8.6.3. The Middle East and Africa Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 - 2025(USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Pfizer Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Route of Administration portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Horizon Pharma plc
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Route of Administration portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Ferring B.V.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Route of Administration portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Bioventus, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Route of Administration portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Sanofi
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Route of Administration portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Flexion Therapeutics, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Route of Administration portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Alkem Laboratories
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Route of Administration portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Anika Therapeutics, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Route of Administration portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Chugai Pharmaceutical Co., Limited
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Route of Administration portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Zimmer Biomet Holdings, Inc.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Route of Administration portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

List of Figures

1. Market research process
2. Market research methodology
3. Global Osteoarthritis Drug Market revenue, 2016 – 2025 (USD Million) 
4. Porter’s five forces analysis
5. Osteoarthritis Drug Market attractiveness analysis, by Drug Class
6. Osteoarthritis Drug Market attractiveness analysis, by Route of Administration
7. Osteoarthritis Drug Market attractiveness analysis, by Distribution Channel 
8. Osteoarthritis Drug Market: Market attractiveness analysis, by region 
9. Company market share analysis, 2018
10. Global Osteoarthritis Drug Market revenue share by Drug Class, 2016 and 2025
11. Global Osteoarthritis Drug Market, 2016 – 2025 (USD Million)
a. Global Corticosteroids market, 2016 – 2025(USD Million)
b. Global NSAIDs market, 2016 – 2025(USD Million)
c. Global viscosupplementation agents market, 2016 – 2025(USD Million)
d. Global others market, 2016 – 2025(USD Million)
12. Global Osteoarthritis Drug Market revenue share by Route of Administration, 2016 and 2025
13. Global Osteoarthritis Drug Market, 2016 – 2025 (USD Million)
a. Global Oral market, 2016 – 2025(USD Million)
b. Global Parenteral market, 2016 – 2025(USD Million)
c. Global Topical Market, 2016-2025(USD Million)
14. Global Osteoarthritis Drug Market revenue share by Distribution Channel, 2016 and 2025
15. Global Osteoarthritis Drug Market, 2016 – 2025 (USD Million)
a. Hospital Pharmacies, 2016 – 2025(USD Million)
b. Retail pharmacies, 2016 – 2025(USD Million)
c. Online Pharmacies, 2016 – 2025(USD Million)


List of Tables

1. Osteoarthritis Drug Market: Market Snapshot                                                                                                                        
2. Drivers of global Osteoarthritis Drug Market: Impact analysis
3. Restraints of Osteoarthritis Drug Market: Impact analysis
4. North America Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
5. North America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025 (USD Million)
6. North America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million) 
7. The U.S. Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million) 
8. The U.S. Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million) 
9. The U.S. Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
10. Rest of North America Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
11. Rest of North America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million) 
12. Rest of North America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million) 
13. Rest of North America Osteoarthritis Drug Market revenue, by Region, 2016 – 2025(USD Million)
14. Europe Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
15. Europe Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
16. Europe Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
17. Germany Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
18. Germany Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
19. Germany Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
20. UK Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
21. UK Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
22. UK Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
23. France Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million) 
24. France Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million) 
25. France Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million) 
26. Rest of Europe Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
27. Rest of Europe Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
28. Rest of Europe Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
29. Asia Pacific Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
30. Asia Pacific Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
31. Asia Pacific Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
32. China Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million) 
33. China Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million) 
34. China Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million) 
35. Japan Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
36. Japan Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
37. Japan Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million) 
38. India Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
39. India Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million)
40. India Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
41. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
42. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million) 
43. Rest of Asia Pacific Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)
44. Latin America Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million)
45. Latin America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million) 
46. Latin America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)  
47. Brazil Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million) 
48. Brazil Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million) 
49. Brazil Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million) 
50. Rest of Latin America Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million) 
51. Rest of Latin America Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million) 
52. Rest of Latin America Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million) 
53. The Middle East and Africa Osteoarthritis Drug Market revenue, by Drug Class, 2016 – 2025(USD Million) 
54. The Middle East and Africa Osteoarthritis Drug Market revenue, by Route of Administration, 2016 – 2025(USD Million) 
55. The Middle East and Africa Osteoarthritis Drug Market revenue, by Distribution Channel, 2016 – 2025(USD Million)

Methodology

Free Analysis

Osteoarthritis is a joint degenerative disorder that affects various joint, which mostly affects the elderly population. In osteoarthritis, the smooth gliding surface between joints that provides easy movement is affected with age. This leads to swelling, pain, tenderness, and stiffness in joints and affects the normal movement and quality of life of an individual. There is no permanent cure for this condition. However, medicines help in suppressing the symptoms to a certain extent, thereby offering relief to patients. The medications used for the osteoarthritis treatment mostly include pain relievers, such as Paracetamol, ibuprofen, naproxen, etc. Osteoarthritis affects the knee, shoulder, lower back, etc.

The primary factor likely to drive the global osteoarthritis drug market over the estimated timeframe is the constantly rising aging population. As per the National Institutes of Health Report, in 2017, nearly 617 million people were 65 years and above. This number is projected to reach around 1.6 billion by the year 2050. The growing prevalence of osteoarthritis among people is another factor expected to promote the expansion of osteoarthritis drug market globally in the future. As per the Centers for Disease Control and Prevention report 2017, there were around 30 million adults in the U.S. suffered from osteoarthritis. FDA approvals for various drugs are expected to create new growth opportunities in this market. Moreover, increasing research and development activities and innovation of new drugs are also expected to support the growth of the global osteoarthritis drug market over the estimated timeframe. However, the low adoption rate and side effects of these drugs might hamper the growth of the osteoarthritis drug market in the future.

Global Osteoarthritis Drug Market

The global osteoarthritis drug market is classified into a drug class, route of administration, and distribution channel. By drug class, the osteoarthritis drug market is segmented into corticosteroids, NSAIDs, viscosupplementation agents, and others. Viscosupplementation agents are expected to expand significantly over the forecast time period. By route of administration, this market is segmented into oral, parenteral, and topical. The parenteral segment is expected to dominate this global market over the forecast timespan. The distribution channel segment includes hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are expected to hold a major market share in the upcoming years.

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa comprise the regional segmentation of the global osteoarthritis drug market. North America is expected to dominate the global osteoarthritis drug market in the future, due to the presence of developed economies, such as the U.S. and Canada. Europe is anticipated to be the second largest region in the osteoarthritis drug market in the upcoming years, owing to the presence of advanced technology. The Asia Pacific osteoarthritis drug market is the third largest and likely to emerge as the fastest growing over the forecast period, owing to the presence of developing economies, such as India and China. The Latin American and the Middle Eastern and African markets are expected to register a sluggish rate of growth over the forecast timeline.

Some major players of the global osteoarthritis drug market include Pfizer Inc., Horizon Pharma plc, Ferring B.V., Bioventus, Inc., Sanofi, Flexion Therapeutics, Inc., Alkem Laboratories, Anika Therapeutics, Inc., Chugai Pharmaceutical Co., Limited, and Zimmer Biomet Holdings, Inc., among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed